Yun Fan

8PUBLICATIONS
19CO-AUTHORS
Cancer therapy (excl. chemotherapy and radiation therapy)Molecular targetsTumour immunologyRadiation therapy
Featured researcher

Get your video featured.

JoVEPublish with JoVE
Journal

Publications (8)

|Nov 06, 2025
Tislelizumab plus sitravatinib or anlotinib as maintenance therapy in extensive-stage small-cell lung cancer: Results of two prospective phase II studies.

Sizhe Yu, Hui Li, Hongyang Lu

|Jul 03, 2024
Spotlight on the treatment of non-small cell lung cancer with rare genetic alterations and brain metastasis: Current status and future perspectives.

Qian Zhang, Kaiyan Chen, Xiaoqing Yu

|Sep 19, 2023
Sintilimab plus anlotinib as second- or third-line therapy in metastatic non-small cell lung cancer with uncommon epidermal growth factor receptor mutations: A prospective, single-arm, phase II trial.

Kaiyan Chen, Yanjun Xu, Zhiyu Huang

|Jun 28, 2022
Real-world utilization of PD-1/PD-L1 inhibitors with palliative radiotherapy in patients with metastatic non-small cell lung cancer.

Zi-Chao Zhou, Kai-Yan Chen, Na Li

|Oct 01, 2021
Efficacy of PD-1/PD-L1 inhibitors in patients with non-small cell lung cancer and brain metastases: A real-world retrospective study in China.

Jiamin Sheng, Hui Li, Xiaoqing Yu

|May 10, 2021
Real-world utilization of EGFR TKIs and prognostic factors for survival in EGFR-mutated non-small cell lung cancer patients with brain metastases.

Xiaoqing Yu, Jiamin Sheng, Guoqiang Pan

Pageof 2

Frequent Collaborators

5 joint publications

Yun Fan

2 joint publications

Zichao Zhou

2 joint publications

Na Li

2 joint publications

Mingying Xie